347 related articles for article (PubMed ID: 15848762)
1. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
Vintém AP; Price NT; Silverman RB; Ramsay RR
Bioorg Med Chem; 2005 May; 13(10):3487-95. PubMed ID: 15848762
[TBL] [Abstract][Full Text] [Related]
2. Alteration in spectral properties on ligand binding reveals flexibility in monoamine oxidase.
Ramsay RR; Jones TZ; Hynson RM
Med Sci Monit; 2005 Sep; 11(9):SR15-20. PubMed ID: 16127378
[TBL] [Abstract][Full Text] [Related]
3. Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.
Li M; Binda C; Mattevi A; Edmondson DE
Biochemistry; 2006 Apr; 45(15):4775-84. PubMed ID: 16605246
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of monoamine oxidase A by the monoamine oxidase B inactivators 1-phenylcyclopropylamine, 1-benzylcyclopropylamine, and N-cyclopropyl-alpha-methylbenzylamine.
Silverman RB; Hiebert CK
Biochemistry; 1988 Nov; 27(22):8448-53. PubMed ID: 3242595
[TBL] [Abstract][Full Text] [Related]
5. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
Nandigama RK; Miller JR; Edmondson DE
Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines.
Wu HF; Chen K; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):888-93. PubMed ID: 8316221
[TBL] [Abstract][Full Text] [Related]
7. Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N.
Mitchell DJ; Nikolic D; Rivera E; Sablin SO; Choi S; van Breemen RB; Singer TP; Silverman RB
Biochemistry; 2001 May; 40(18):5447-56. PubMed ID: 11331009
[TBL] [Abstract][Full Text] [Related]
8. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.
Malcomson T; Yelekci K; Borrello MT; Ganesan A; Semina E; De Kimpe N; Mangelinckx S; Ramsay RR
FEBS J; 2015 Aug; 282(16):3190-8. PubMed ID: 25755053
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A.
Miller JR; Edmondson DE
Biochemistry; 1999 Oct; 38(41):13670-83. PubMed ID: 10521274
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.
Hubálek F; Binda C; Li M; Herzig Y; Sterling J; Youdim MB; Mattevi A; Edmondson DE
J Med Chem; 2004 Mar; 47(7):1760-6. PubMed ID: 15027867
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of human liver monoamine oxidase B in Pichia pastoris.
Newton-Vinson P; Hubalek F; Edmondson DE
Protein Expr Purif; 2000 Nov; 20(2):334-45. PubMed ID: 11049757
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine.
Silverman RB; Zieske PA
Biochemistry; 1985 Apr; 24(9):2128-38. PubMed ID: 3995007
[TBL] [Abstract][Full Text] [Related]
13. Deuterium isotope effect studies on the MAO-B catalyzed oxidation of 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine.
Anderson AH; Kuttab S; Castagnoli N
Biochemistry; 1996 Mar; 35(10):3335-40. PubMed ID: 8605171
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated phenylcyclopropylamines. Part 4: effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines.
Ye S; Yoshida S; Fröhlich R; Haufe G; Kirk KL
Bioorg Med Chem; 2005 Apr; 13(7):2489-99. PubMed ID: 15755651
[TBL] [Abstract][Full Text] [Related]
15. [Isolation and characterization of an evolutionary precursor of human monoamine oxidases A and B].
Singer TP; Iankovskaia VL; Bernard S; Cronin C; Sablin SO
Vopr Med Khim; 1997; 43(6):440-56. PubMed ID: 9503562
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.
Nimkar SK; Anderson AH; Rimoldi JM; Stanton M; Castagnoli KP; Mabic S; Wang YX; Castagnoli N
Chem Res Toxicol; 1996 Sep; 9(6):1013-22. PubMed ID: 8870990
[TBL] [Abstract][Full Text] [Related]
17. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
Ramsay RR
Vopr Med Khim; 1997; 43(6):457-70. PubMed ID: 9503563
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine.
Mitchell DJ; Nikolic D; Jang MH; van Breemen RB; Hille R; Silverman RB
Biochemistry; 2001 Jul; 40(29):8523-30. PubMed ID: 11456490
[TBL] [Abstract][Full Text] [Related]
19. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
[TBL] [Abstract][Full Text] [Related]
20. Alanine scanning mutagenesis of the testosterone binding site of rat 3 alpha-hydroxysteroid dehydrogenase demonstrates contact residues influence the rate-determining step.
Heredia VV; Cooper WC; Kruger RG; Jin Y; Penning TM
Biochemistry; 2004 May; 43(19):5832-41. PubMed ID: 15134457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
